Literature DB >> 21103174

New pharmacotherapies for treating the neurobiology of alcohol and drug addiction.

Helen M Pettinati1, Amanda R Rabinowitz.   

Abstract

Entities:  

Year:  2006        PMID： 21103174      PMCID： PMC2990620     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  11 in total

Review 1.  Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders.

Authors:  William R Miller; Paula L Wilbourne
Journal:  Addiction       Date:  2002-03       Impact factor: 6.526

2.  Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.

Authors:  James C Garbutt; Henry R Kranzler; Stephanie S O'Malley; David R Gastfriend; Helen M Pettinati; Bernard L Silverman; John W Loewy; Elliot W Ehrich
Journal:  JAMA       Date:  2005-04-06       Impact factor: 56.272

3.  Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.

Authors:  H M Pettinati; J R Volpicelli; J D Pierce; C P O'Brien
Journal:  J Addict Dis       Date:  2000

4.  A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Authors:  Charles A Dackis; Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Charles P O'Brien
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

Review 5.  The status of disulfiram: a half of a century later.

Authors:  Jesse J Suh; Helen M Pettinati; Kyle M Kampman; Charles P O'Brien
Journal:  J Clin Psychopharmacol       Date:  2006-06       Impact factor: 3.153

6.  The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; S Patricia Chou; Mary C Dufour; Roger P Pickering
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

Review 7.  Naltrexone in the treatment of alcoholism: a clinical review.

Authors:  C P O'Brien; L A Volpicelli; J R Volpicelli
Journal:  Alcohol       Date:  1996 Jan-Feb       Impact factor: 2.405

8.  A pilot trial of topiramate for the treatment of cocaine dependence.

Authors:  Kyle M Kampman; Helen Pettinati; Kevin G Lynch; Charles Dackis; Thorne Sparkman; Catherine Weigley; Charles P O'Brien
Journal:  Drug Alcohol Depend       Date:  2004-09-06       Impact factor: 4.492

9.  Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial.

Authors:  Kathleen M Carroll; Lisa R Fenton; Samuel A Ball; Charla Nich; Tami L Frankforter; Julia Shi; Bruce J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2004-03

10.  The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

Authors:  Karl Mann; Philippe Lehert; Marsha Y Morgan
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455
View more
  4 in total

1.  The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence.

Authors:  Helen M Pettinati; Raymond F Anton; Mark L Willenbring
Journal:  Psychiatry (Edgmont)       Date:  2006-10

Review 2.  Preclinical Medication Development: New Targets and New Drugs.

Authors:  Chelsea R Kasten; Stephen L Boehm
Journal:  Alcohol Clin Exp Res       Date:  2016-05-14       Impact factor: 3.455

Review 3.  15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse.

Authors:  Pauline Charbogne; Brigitte L Kieffer; Katia Befort
Journal:  Neuropharmacology       Date:  2013-09-10       Impact factor: 5.250

Review 4.  Alcohol and the Brain.

Authors:  David Nutt; Alexandra Hayes; Leon Fonville; Rayyan Zafar; Emily O C Palmer; Louise Paterson; Anne Lingford-Hughes
Journal:  Nutrients       Date:  2021-11-04       Impact factor: 5.717
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.